Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Priyamvada Prathima

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Journal of Chemical Theory and Computation|November 22, 2024
Advancing Membrane-Associated Protein Docking with Improved Sampling and Scoring in RosettaRituparna Samanta, Ameya Harmalkar, Priyamvada Prathima, et al.
Biorxiv : the Preprint Server for Biology|July 19, 2024
Advancing membrane-associated protein docking with improved sampling and scoring in RosettaRituparna Samanta, Ameya Harmalkar, Priyamvada Prathima, et al.
The Journal of Experimental Medicine|February 27, 2024
Framework for in vivo T cell screensLauren E Milling, Samuel C Markson, Qin Tjokrosurjo, et al.
Nature Immunology|August 12, 2025
A STUB1-CHIC2 complex inhibits CD8<sup>+</sup> T cells to restrain tumor immunityMartin W LaFleur, Lauren E Milling, Priyamvada Prathima, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Journal of Chemical Theory and Computation|November 22, 2024
Advancing Membrane-Associated Protein Docking with Improved Sampling and Scoring in RosettaRituparna Samanta, Ameya Harmalkar, Priyamvada Prathima, et al.
Biorxiv : the Preprint Server for Biology|July 19, 2024
Advancing membrane-associated protein docking with improved sampling and scoring in RosettaRituparna Samanta, Ameya Harmalkar, Priyamvada Prathima, et al.
The Journal of Experimental Medicine|February 27, 2024
Framework for in vivo T cell screensLauren E Milling, Samuel C Markson, Qin Tjokrosurjo, et al.
Nature Immunology|August 12, 2025
A STUB1-CHIC2 complex inhibits CD8<sup>+</sup> T cells to restrain tumor immunityMartin W LaFleur, Lauren E Milling, Priyamvada Prathima, et al.
Pageof 1